Communiqués Labcorp Holdings Inc.

Actions

LH

US5049221055

Installations et services en soins de santé

Marché Fermé - NYSE 22:00:02 21/08/2026			Varia. 5j.	Varia. 1 janv.
336,34 ^USD	+1,06%		+5,72%	+34,06%

20/08	Le secteur pharmaceutique mise massivement sur l'IA dans l'espoir de réduire les coûts et les délais	RE
18/08	Labcorp Holdings : une administratrice cède pour 954 060 $ d'actions, selon un récent document de la SEC	MT

Communiqués

18/08	Labcorp and NACHC Launch Strategic Alliance to Strengthen Health Center Leadership and Advance Community Health	PR
17/08	Labcorp to Host Investor Day on September 10, 2026	PR
10/08	Labcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma	PR
04/08	Labcorp Launches FDA-Approved PTEN Companion Diagnostic for Prostate Cancer	PR
30/07	Labcorp: Q2 Earnings Snapshot	AQ
30/07	Labcorp Announces 2026 Second Quarter Results; Raises Full Year 2026 Guidance	PR
27/07	Labcorp Launches Marker by Labcorp™ Genetic Health Panel, Expanding Consumer Access to Hereditary Genetic Risk Testing	PR
09/07	Labcorp Declares Quarterly Dividend	PR
30/06	Labcorp to Announce Second Quarter 2026 Financial Results on July 30, 2026	PR
23/06	Labcorp Announces Nationwide Availability of ColoSense(R), the First FDA-Approved RNA-Based At-Home Colorectal Cancer Screening Test	AQ
22/06	Labcorp Announces Nationwide Availability of ColoSense®, the First FDA-Approved RNA-Based At-Home Colorectal Cancer Screening Test	PR
29/05	Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer	PR
28/05	Labcorp Launches Expanded DPYD Test to Identify Cancer Patients at Risk for Severe Chemotherapy Side Effects	PR
27/05	Labcorp to Present at the Jefferies Global Healthcare Conference	PR
20/05	Labcorp Launches MyLabcorp™, a New AI-Powered Mobile App Designed to Help Consumers Understand Lab Results and Track Health Trends Over Time	PR
12/05	Labcorp and Epic Expand Collaboration to Advance Diagnostic Integration across Hospitals and Health Systems	PR
07/05	Labcorp : Publishes 2025 Corporate Responsibility Report, Highlighting Progress in Sustainability, Access to Care and Employee Well-Being	PU
01/05	Labcorp : Corporate Responsibility Report (2001700-0326-1 BRO Corporate%20responsibility%20report%202025 FINAL)	PU
30/04	Labcorp: Q1 Earnings Snapshot	AQ
30/04	Labcorp Announces 2026 First Quarter Results; Raises Full Year 2026 Guidance	PR
22/04	Labcorp Launches FDA-Approved Companion Diagnostic to Identify Patients with Ovarian Cancer Eligible for KEYTRUDA®	PR
15/04	Labcorp Launches FDA-Cleared Fentanyl Test Delivering Results in 10 Minutes	PR
14/04	Labcorp Introduces AI-Powered Real-World Data Platform with AWS and Datavant to Accelerate Alzheimer's Research	PR
13/04	Children's Hospital of Philadelphia and Labcorp Announce a Collaboration to Accelerate Access to Advanced Pediatric Diagnostics Nationwide	PR
09/04	Labcorp Declares Quarterly Dividend	PR